The Sympathetic Nervous System: An Unlikely Regulator of Growth and Organ Health
A groundbreaking study published in Communications Biology reveals a novel neurodevelopmental pathway that controls organismal growth through liver-derived insulin-like growth factor 1 (IGF-1), independent of the classic growth hormone axis. Researchers discovered that proper sympathetic nervous system innervation of the liver during the perinatal period is critical for regulating body size. Disruption of this hepatic sympathetic innervation leads to significant liver pathology, including steatosis and fibrosis, which in turn impairs the GHR-JAK2-STAT5 signaling pathway and the biosynthesis of IGF-1. This research establishes a primary link between neural development, end-organ health, and systemic growth regulation, highlighting a previously underappreciated mechanism with profound implications for understanding growth disorders and metabolic liver disease.
Study Significance: For nephrology professionals, this discovery of a neuro-hepatic axis governing growth and fibrosis has direct parallels to renal physiology and pathology. The renin-angiotensin-aldosterone system (RAAS) and renal sympathetic nervous system activity are central to blood pressure regulation, sodium balance, and the progression of chronic kidney disease (CKD). This research suggests that neural miswiring could be a foundational element in other organ-specific fibrotic diseases, including diabetic nephropathy and hypertensive nephrosclerosis. Understanding these neurodevelopmental origins may open new avenues for preventing end-stage renal disease (ESRD) by targeting neural pathways early in life, potentially shifting the management of CKD from late-stage intervention to early neuro-modulatory strategies.
Source →Stay curious. Stay informed — with Science Briefing.
Always double check the original article for accuracy.
